L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity
Authors:
- Ruham Alshiekh-NasanyRARuham Alshiekh-Nasany
- Dan DouerDDDan Douer
- 4 February 2016
- journal article
- editorial
- Published by S. Karger AG in Acta Haematologica
- Vol. 135 (4) , 208-210
Abstract
Introduction: Similar to pediatric regimens, multiple doses of L-asparaginase (PEG-Asp) are being increasingly used in adults with newly diagnosed acute lymphoblastic leukemia (ALL) with promising results. One of the most common side effects of the drug in adults is high-grade hyperbilirubinemia and transaminitis. Despite being almost always reversible and may not recur, clinicians may still be reluctant to continue with PEG-Asp in patients with liver toxicity, losing the benefit from multiple doses of the drug. Case Report: We describe a case of adult ALL who developed PEG-Asp-related high grade liver toxicity. The rising hyperbilirubinemia and transaminitis rapidly and permanently reversed using the amino-acid derivative L-carnitine. This case goes in line with similar observations in animal models and humans. Conclusion:L-Carnitine may show therapeutic benefit in PEG-Asp-related hepatotoxicity and should be considered in clinical trials of the drug.Keywords
This publication has 9 references indexed in Scilit:
- Recent developments in l-asparaginase discovery and its potential as anticancer agentCritical Reviews in Oncology/Hematology, 2016
- Effect of carnitine‐orotate complex on glucose metabolism and fatty liver: A double‐blind, placebo‐controlled studyJournal of Gastroenterology and Hepatology, 2014
- Successful treatment ofl-asparaginase-induced severe acute hepatotoxicity using mitochondrial cofactorsLeukemia & Lymphoma, 2013
- L-Carnitine Ameliorates L-Asparaginase-Induced Acute Liver Toxicity in Steatotic Rat LiversChemotherapy, 2013
- L-Carnitine for Acute Valproic Acid Overdose: A Systematic Review of Published CasesAnnals of Pharmacotherapy, 2010
- L-Carnitine Supplementation to Diet: A New Tool in Treatment of Nonalcoholic Steatohepatitis—A Randomized and Controlled Clinical TrialAmerican Journal of Gastroenterology, 2010
- Effects of Carnitine on Peripheral Blood Mitochondrial DNA Copy Number and Liver Function in Non-Alcoholic Fatty Liver DiseaseThe Korean Journal of Gastroenterology, 2010
- Hepatoprotective effect of l-carnitine against acute acetaminophen toxicity in miceExperimental and Toxicologic Pathology, 2007
- Histopathological Features of L-Asparaginase-Induced Liver DiseaseSeminars in Liver Disease, 2003